Cayman’s SARS-CoV-2 Neutralizing Antibody Human Plasma Control Set contains human plasma collected prior to the SARS-CoV-2 pandemic that has been spiked at low, mid, or high levels with a recombinant human anti-SARS-CoV-2 neutralizing IgG antibody. A negative control, free of neutralizing antibody, is also included. The levels of neutralizing antibody to be added to each control were determined by screening numerous positive and negative samples using Cayman’s SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit (Item No. 502070). The amount of neutralizing antibody spiked into the controls was designed to be representative of the range of antibody levels found in a typical sample set.
Available on backorder
A set of SARS-CoV-2 neutralizing antibody human plasma controls containing negative control plasma, as well as positive control plasma spiked with low, mid, and high levels of recombinant human anti-SARS-CoV-2 neutralizing IgG antibody
Synonyms:
Immunogen:
Formulation:
Isotype:
Applications:
Origin:
Stability: 180 days
Application|ELISA||Research Area|Immunology & Inflammation|Pulmonary Diseases||Research Area|Infectious Disease|Viral Diseases|Coronaviruses
For the quantitation of Mouse Lcn2 concentrations in cell culture supernates, serum, plasma(heparin, EDTA) and urine.
Available on backorder
For quantitative detection of human LILRB2 in cell culture supernates, serum and plasma (heparin, EDTA, citrate).
Available on backorder
For quantitative detection of human LILRA5 in cell culture supernates, serum and plasma (heparin, EDTA, citrate).
Available on backorder